ERBB and HEMP are both far too small for me to trade. MGT looks like a "short on rally" play. But its borrow cost is now 94+%. I let it pass a while back due to the borrow cost. Hard to borrow also.
MCRB fell almost 70% on Friday. It's a microbiome therapeutics company. Interim P2 result for lead product failed. It's a near-term short-on-rally play. Borrow cost 1.9% or so. Just received a >100 million royalty payment in Q1. Strong balance sheet. Won't short it long term. But I won't go long until it nears profitability, which is years away.
I'm also studying more carefully if the fraud accusation on SPU years ago had merit. But for a Chinese stock that has delayed 10-Q/10-K filings, dwindling profit and also rallied 5 or 6 times in the past couple of weeks it looks a good short. Actually I shorted it a few days ago but have covered. Borrow cost spiked in the past couple of days to now 75%. But I normally short stocks as near-day-trades. So sometimes high borrow cost does work for me.
From now on, I think we should move this kind of discussion somewhere else. Otherwise, other people on this board is going to get annoyed.
Good luck and keep in touch.
Market Data 
Markets 
AI
